| 中文名称: | 6 - 甲基-1,1' - [2 - (5 - 甲基- 2-苯基- 4-恶唑基)乙基] - 螺[4H - 3-1,1 - 苯并恶嗪- 4,4' -哌啶]-2(1H)-酮 |
| 中文同义词: | 6 - 甲基-1,1' - [2 - (5 - 甲基- 2-苯基- 4-恶唑基)乙基] - 螺[4H - 3-1,1 - 苯并恶嗪- 4,4' -哌啶]-2(1H)-酮;6-甲基-1'-[2-(5-甲基-2-苯基-4-恶唑基)乙基]螺[4H-3,1-苯并恶嗪-4,4'-哌啶]-2(1H)-酮;6-甲基-1'-[2-(5-甲基-2-苯基-噁唑-4-基)乙基]-螺[4H-3,1-苯并噁嗪-4,4'-哌啶]-2(1H)-酮;6-甲基-1'-(2-(5-甲基-2-苯基恶唑-4-基)乙基)螺[苯并[D][1,3]恶嗪-4,4'-哌啶]-2(1H)-酮;化合物RS 504393;6-甲基-1'-(2-(5-甲基-2-苯基恶唑-4-基)乙基)螺[苯并[D][1,3]恶嗪-4,4'-哌啶]-2(1H)-一;6 - 甲基-1,1' - [2 - (5 - 甲基- 2-苯基- 4-恶唑基)乙基] - 螺[4H - 3-1,1 - 苯并恶嗪- 4,4' -哌啶]-2(1H)-酮 1级;RS504393,CCR2趋化因子受体拮抗剂 |
| 英文名称: | RS 504393 |
| 英文同义词: | Spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one, 6-Methyl-1'-[2-(5-Methyl-2-phenyl-4-oxazolyl)ethyl]-;6-Methyl-1'-[2-(5-Methyl-2-phenyl-4-oxazolyl)ethyl]-spiro[4H-3,1-benzoxazine-4,4'-piperidi;6-Methyl-1'-(2-(5-Methyl-2-phenyloxazol-4-yl)ethyl)spiro[benzo[d][1,3]oxazine-4,4'-piperidin]-2(1H)-one;6-Methyl-1'-(2-(5-methyl-2-phenyloxazol-4-yl)ethyl)spiro-[benzo[d][1,3]oxazine-4,4'-piperidin]-2(;6-Methyl-1'-(2-(5-methyl-2-phenyloxazol-4-yl)ethyl)spiro-[benzo[d][1,3]oxazine-4,4'-piperidin];RS 504393;6-Methyl-1'-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one;RS-504393; RS504393 |
| CAS号: | 300816-15-3 |
| 分子式: | C25H27N3O3 |
| 分子量: | 417.5 |
| EINECS号: | |
| Mol文件: | 300816-15-3.mol |